Invivoscribe® Receives FDA Approval for the LeukoStrat® CDx FLT3 Mutation Assay Companion Diagnostic Test for the Selection of Patients for Rydapt® and is the First Companion Diagnostic for AML

SAN DIEGO, April 28, 2017 (GLOBE NEWSWIRE) — Invivoscribe® Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the fields of oncology, personalized molecular diagnostics® and personalized molecular medicine®, today announces the premarket approval of LeukoStrat® CDx FLT3 Mutation Assay.  Due to current labeling for […]

Taconic Biosciences Expands Microbiome Product and Service Platform

HUDSON, N.Y., April 26, 2017 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in genetically engineered mouse models and associated services and the only commercial provider of germ-free mice, announced that effective April 26, 2017 they will expand their microbiome product and services platform to include custom Fecal Microbiota Transplantation (FMT) services. To support these […]

Taconic Biosciences Announces Release of New Parkinson’s Disease Animal Model

HUDSON, N.Y., April 25, 2017 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced that effective April 17, 2017, in conjunction with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), began commercial distribution of a new Parkinson’s disease mouse Model 13940 (C57BL/6- Lrrk2tm4.1Arte). The development of […]